Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Gil

Showing results (61-70 of 71) with videos related to

Pageof 8
Sort By:
Biorxiv : the Preprint Server for Biology|February 26, 2024
A Broad-Spectrum Multi-Antigen mRNA/LNP-Based Pan-Coronavirus Vaccine Induced Potent Cross-Protective Immunity Against Infection and Disease Caused by Highly Pathogenic and Heavily Spike-Mutated SARS-CoV-2 Variants of Concern in the Syrian Hamster ModelSwayam Prakash, Nisha R Dhanushkodi, Mahmoud Singer, et al.
The Journal of Thoracic and Cardiovascular Surgery|July 25, 2023
Impact of thoracic endovascular aortic repair following blunt traumatic thoracic aortic injury on blood pressureAndrea Guala, Daniel Gil-Sala, Marvin E Garcia Reyes, et al.
European Journal of Haematology|January 8, 2026
Evolving Patterns of EBV-Associated PTLD After Allogeneic Stem Cell Transplantation: Frequency, Characteristics and Outcomes in a Multicenter GETH-TC StudyIrene García-Cadenas, Manuel Guerreiro, Lucrecia Yañez, et al.
Cytotherapy|December 12, 2025
GMP-compliant manufacturing of allogeneic peripheral blood CAR-NK cells for the treatment of acute myeloid leukemiaLaura Córdoba-Espejo, Laura Sánchez-Vega, Almudena García-Ortiz, et al.
European Journal of Haematology|July 26, 2020
Clinical course and risk factors for mortality from COVID-19 in patients with haematological malignanciesJosé María Sanchez-Pina, Mario Rodríguez Rodriguez, Nerea Castro Quismondo, et al.
Frontiers in Immunology|January 25, 2024
Corrigendum: Personalized monitoring of circulating tumor DNA with a specific signature of trackable mutations after chimeric antigen receptor T-cell therapy in follicular lymphoma patientsAna Jiménez-Ubieto, Alejandro Martín-Muñoz, María Poza, et al.
Journal for Immunotherapy of Cancer|December 30, 2025
Affinity-matured CD72-targeting nanobody CAR T cells enhance elimination of antigen-low B-cell malignanciesAdila Izgutdina, Tasfia Rashid, William C Temple, et al.
Frontiers in Immunology|May 15, 2026
Clinical, laboratory and genetic characteristics of VEXAS syndrome: a study on behalf of GESMDMarta Fonseca-Santos, Borja Puertas, Javier Arzuaga-Méndez, et al.
Biorxiv : the Preprint Server for Biology|June 4, 2025
Affinity-matured CD72-targeting Nanobody CAR T-cells Enhance Elimination of Antigen-Low B-cell MalignanciesAdila Izgutdina, Tasfia Rashid, William C Temple, et al.
Biorxiv : the Preprint Server for Biology|March 11, 2024
Targeting high-risk multiple myeloma genotypes with optimized anti-CD70 CAR-T cellsCorynn Kasap, Adila Izgutdina, Bonell Patiño-Escobar, et al.
Pageof 8

Showing results (61-70 of 71) with videos related to

Sort By:
Pageof 8
Biorxiv : the Preprint Server for Biology|February 26, 2024
A Broad-Spectrum Multi-Antigen mRNA/LNP-Based Pan-Coronavirus Vaccine Induced Potent Cross-Protective Immunity Against Infection and Disease Caused by Highly Pathogenic and Heavily Spike-Mutated SARS-CoV-2 Variants of Concern in the Syrian Hamster ModelSwayam Prakash, Nisha R Dhanushkodi, Mahmoud Singer, et al.
The Journal of Thoracic and Cardiovascular Surgery|July 25, 2023
Impact of thoracic endovascular aortic repair following blunt traumatic thoracic aortic injury on blood pressureAndrea Guala, Daniel Gil-Sala, Marvin E Garcia Reyes, et al.
European Journal of Haematology|January 8, 2026
Evolving Patterns of EBV-Associated PTLD After Allogeneic Stem Cell Transplantation: Frequency, Characteristics and Outcomes in a Multicenter GETH-TC StudyIrene García-Cadenas, Manuel Guerreiro, Lucrecia Yañez, et al.
Cytotherapy|December 12, 2025
GMP-compliant manufacturing of allogeneic peripheral blood CAR-NK cells for the treatment of acute myeloid leukemiaLaura Córdoba-Espejo, Laura Sánchez-Vega, Almudena García-Ortiz, et al.
European Journal of Haematology|July 26, 2020
Clinical course and risk factors for mortality from COVID-19 in patients with haematological malignanciesJosé María Sanchez-Pina, Mario Rodríguez Rodriguez, Nerea Castro Quismondo, et al.
Frontiers in Immunology|January 25, 2024
Corrigendum: Personalized monitoring of circulating tumor DNA with a specific signature of trackable mutations after chimeric antigen receptor T-cell therapy in follicular lymphoma patientsAna Jiménez-Ubieto, Alejandro Martín-Muñoz, María Poza, et al.
Journal for Immunotherapy of Cancer|December 30, 2025
Affinity-matured CD72-targeting nanobody CAR T cells enhance elimination of antigen-low B-cell malignanciesAdila Izgutdina, Tasfia Rashid, William C Temple, et al.
Frontiers in Immunology|May 15, 2026
Clinical, laboratory and genetic characteristics of VEXAS syndrome: a study on behalf of GESMDMarta Fonseca-Santos, Borja Puertas, Javier Arzuaga-Méndez, et al.
Biorxiv : the Preprint Server for Biology|June 4, 2025
Affinity-matured CD72-targeting Nanobody CAR T-cells Enhance Elimination of Antigen-Low B-cell MalignanciesAdila Izgutdina, Tasfia Rashid, William C Temple, et al.
Biorxiv : the Preprint Server for Biology|March 11, 2024
Targeting high-risk multiple myeloma genotypes with optimized anti-CD70 CAR-T cellsCorynn Kasap, Adila Izgutdina, Bonell Patiño-Escobar, et al.
Pageof 8